このアイテムのアクセス数: 72

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
MPH.0000000000002482.pdf595.43 kBAdobe PDF見る/開く
タイトル: Use of Cabozantinib to Treat MET-amplified Pediatric Colorectal Cancer
著者: Fukui, Sadahiro
Umeda, Katsutsugu  kyouindb  KAKEN_id
Kubota, Hirohito
Iwai, Atsushi
Akazawa, Ryo
Isobe, Kiyotaka
Tanaka, Kuniaki
Kouzuki, Kagehiro
Kawabata, Naoko
Saida, Satoshi  kyouindb  KAKEN_id
Kato, Itaru  kyouindb  KAKEN_id
Hiramatsu, Hidefumi  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0003-3136-5670 (unconfirmed)
Itatani, Yoshiro
Funakoshi, Taro
Adachi, Souichi
Takita, Junko  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-2452-6520 (unconfirmed)
著者名の別形: 福井, 貞弘
梅田, 雄嗣
窪田, 博仁
岩井, 篤
赤澤, 嶺
磯部, 清孝
田中, 邦明
上月, 景弘
川端, 奈央子
才田, 聡
加藤, 格
平松, 英文
板谷, 喜朗
船越, 太郎
足立, 壯一
滝田, 順子
キーワード: colorectal cancer
pediatric
cancer gene panel testing
MET inhibitor
cabozantinib
発行日: Apr-2023
出版者: Wolters Kluwer Health
誌名: Journal of Pediatric Hematology/Oncology
巻: 45
号: 3
開始ページ: e423
終了ページ: e426
抄録: Pediatric colorectal cancer (CRC) is extremely rare, with little information about genetic profiles compared with adult CRC. Here, a 13-year-old male with advanced CRC underwent cancer gene panel testing, which detected 4 genetic abnormalities (MET amplification in addition to TP53, SMAD4, and CTNNA1 mutations) that might be associated with a poor prognosis. Based on high-level MET amplification, he received a multikinase inhibitor, cabozantinib, after failure of first-line and second-line chemotherapy, resulting in transient disease stabilization. Tailored targeted therapy based on molecular profiling can be an effective treatment strategy for rare cancers such as pediatric CRC.
著作権等: This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Pediatric Hematology/Oncology. The published version of record [Fukui, Sadahiro MD*; Umeda, Katsutsugu MD*; Kubota, Hirohito MD*; Iwai, Atsushi MD*; Akazawa, Ryo MD*; Isobe, Kiyotaka MD*; Tanaka, Kuniaki MD*; Kouzuki, Kagehiro MD*; Kawabata, Naoko MD*; Saida, Satoshi MD*; Kato, Itaru MD*; Hiramatsu, Hidefumi MD*; Itatani, Yoshiro MD†; Funakoshi, Taro MD‡; Adachi, Souichi MD§; Takita, Junko MD*. Use of Cabozantinib to Treat MET-amplified Pediatric Colorectal Cancer. Journal of Pediatric Hematology/Oncology 45(3):p e423-e426, April 2023.] is available online at: https://doi.org/10.1097/MPH.0000000000002482
The full-text file will be made open to the public on 1 April 2024 in accordance with publisher's 'Terms and Conditions for Self-Archiving'.
This is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。
URI: http://hdl.handle.net/2433/279949
DOI(出版社版): 10.1097/MPH.0000000000002482
PubMed ID: 35536994
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。